Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting ( out Ferring Pharmaceuticals Ferring P...)

Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting

out Ferring Pharmaceuticals

Ferring Pharmaceuticals, part of the Ferring Group, a privately owned, international pharmaceutical company, markets BRAVELLE(R), MENOPUR(R), REPRONEX(R) and NOVAREL (chorionic gonadotropin for injection, USP) in the U.S. to infertility specialists and their patients. Ferring also offers the Q-CAP(TM), the first and only needle-free reconstitution device, for use with its fertility treatments.

Ferring's line of orthopaedic and urology products includes EUFLEXXA(TM), hyaluronic acid for pain from osteoarthritis in the knee. Other products include ACTHREL(R) (corticorelin ovine triflutate for injection) for the differential diagnosis of Cushing's syndrome and DESMOPRESSIN ACETATE in injectable and rhinal tube forms for the treatment of diabetes insipidus and primary nocturnal enuresis.

The Ferring Group specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, gastroenterology, obstetrics/gynecology and infertility. For more information, call 888-337-7464 or visit www.ferringusa.com or www.ferringfertility.com.

* Crinone (progesterone vaginal gel) 8% is marketed by Columbia

Laboratories.

Please contact Andrea Preston for MENOPUR and BRAVELLE full prescribing information

CONTACT: Andrea Preston of Kovak-Likly Communications, +1-203-762-8833, or, for Ferring Pharmaceuticals apreston@klcpr.com

Web site: http://www.ferringusa.com/http://www.ferringfertility.com/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

Page: 1 2 3 4 5
Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia

Post Your Comments:

(Date:11/20/2009)...K, Nov. 20 Medco Health ...g to a transformation in American healthcare throu...ready delivering higher quality clinical care and ...aking medicine smarter for the benefit of patients...ed how the elements in its strategy enable "Smarte...

(Date:11/20/2009)... YORK, Nov. 20 Reportlinker.com an...able in its catalogue. ,, Pipettes & Pipet.../www.reportlinker.com/p0164373/Pipettes--Pipettors...ewswire&utm_medium=pr&utm_campaign=prnewsw...an integral part of any research laboratory. Large...

(Date:11/20/2009)... YORK, Nov. 20 Reportlinker.com an...able in its catalogue. ,, Medical Adhesives an...w.reportlinker.com/p0164242/Medical-Adhesives-and-...wswire&utm_medium=pr&utm_campaign=prnewswi...ts is gaining preeminence in medical devices and e...

Breaking Medicine Technology:Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2 Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3 Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4 Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12 Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2 Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3 Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4 Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5 Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6 Almost Family to Present at Two Upcoming Conferences 47674 1 Almost Family to Present at Two Upcoming Conferences 47674 2 Seventy three scientists elected to the American Academy of Microbiology 8700 1 Seventy three scientists elected to the American Academy of Microbiology 8700 2 Seventy three scientists elected to the American Academy of Microbiology 8700 3 Seventy three scientists elected to the American Academy of Microbiology 8700 4 Leading Patient Advocacy Organizations United on Health Care Reform Principles 47671 1 Leading Patient Advocacy Organizations United on Health Care Reform Principles 47671 2 Leading Patient Advocacy Organizations United on Health Care Reform Principles 47671 3

[0] Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost [0] Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective [0] Reportlinker Adds Medical Adhesives and Sealants - A US Market Review

... from Phase III Intergroupe Francophone du Myelome...ss., July 02, 2007 /PRNewswire-FirstCall/ --,Mille...w data were,presented on the comparative Phase III... in newly diagnosed multiple myeloma (MM),patients...ntation,(SCT), the VELCADE based therapy produced ...

...pdate to Timeline for Second Pivotal Phase 3 Trial...ll/ -- Advanced Life,Sciences Holdings, Inc. , tod...cacy data from Trial CL-06, the first of two,pivot...safety and,effectiveness of cethromycin, a novel o...ty acquired pneumonia (CAP). The Company,also prov...

Other Medicine Technology:Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2 Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3 Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4 Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5 Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6 Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2 Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3 Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4 Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5 Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6 Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7

Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial

(Date:11/21/2009)... NH based medical credentialing software c...try to form a partnerhsip with Amerinet, Inc., the...ership will help to transform quality care within ...(Vocus) November 21, 2009 -- ISG Group, LLC, doing...w agreement with Amerinet Inc., a leading national...

(Date:11/21/2009)... HAPPYneuron,s most popular and addictive ...nd iPod Touch. , Mountain...,s most popular and addictive game, SplitWords, is... Words is designed to help banish that ,tip of the...hone brain game challenges the brain by encouragi...

(Date:11/21/2009)... New Haven Dental Group merges their pract...ord, CT. , (PRWEB) Novemb...ed of partners Dr. David Gibson, Dr. Dean Cloutier...just merged their growing practice with that of es...r. Pickman decided he wanted to retire from dentis...

(Date:11/20/2009)...ring Neurologist Closer to Understanding Brain Wir...wire-USNewswire/ -- Dr. Jeremy Schmahmann, Profess...ologist at the Massachusetts General Hospital in B...oratory,s research on the new field of study calle...ndation. ,, Dr. Schmahmann is an award-winning ...

(Date:11/20/2009)...INGTON, Nov. 20 The Am...to modify health care reform legislation released ... health insurance individual coverage mandate. The...mandate will minimize adverse selection stemming f...ibed by the bill. ,, "The individual mandate la...

Breaking Medicine News(10 mins):Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2 Health News:HAPPYneuron releases iPhone Brain Game 2 Health News:HAPPYneuron releases iPhone Brain Game 3 Health News:New Haven Dental Group Expands Their Vision 2 Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2 Health News:Actuaries to Senate: Strengthen Individual Mandate 2

[0] IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care [0] HAPPYneuron releases iPhone Brain Game [0] New Haven Dental Group Expands Their Vision [0] MINDlink Foundation Launches to Connect the Cerebellum to Cures [0] Actuaries to Senate: Strengthen Individual Mandate

...MILLS, Md., Oct. 30 Medifast, Inc.,(NYSE: MED ) ... of fiscal,year 2008 financial results for the per... 6, 2008. The Company will hold a conference call ...412) 317-6760, or can listen via a live Internet w...

...inated as One of the Top 10 Most Interesting Metab... MEETING, Pa., Oct. 30 Genaera,Corporation (NASDA...utic Area,Partnerships Conference being held Novem...view on MSI-1436 for the,treatment of type 2 diabe...

...ELES, Oct. 30 Cardo Medical, a company engaged,in...nounces the FDA 510k,clearance of its Align 360 To...s planned for commercial release during the second...earance for its,Uni-Compartmental and Patello-Femo...

... Raises 2008 EPS Outlook and Announces 2009 Operat...lth,Services, Inc. (Nasdaq: GTIV ), a leading pro... reported third quarter results, led by 17% revenu...ductivity to enhance its industry leadership., (L...

...INGTON, Oct. 30 Statement by SEIU,Secretary-Treas...ial:, "We,re at a defining moment. In six days, v... who will be responsible for rescuing our nation f...now--tax cuts for the middle class, affordable,hea...

... Clinicians can now access Lexi... devices with wireless connectivity. , ...8 --Lexi-Comp, Inc., a provider of clinical inform...ug, disease, and formulary content on smartphones ...

Medifast, Inc. to Announce Third Quarter of Fiscal Year 2008 Financial Results on Thursday, November 6, 2008 Genaera to Present at Therapeutic Area Partnerships 2008 Cardo Medical Announces FDA Clearance of the Align 360 Total Knee System Gentiva Reports Third Quarter Revenue and Profit Growth Obama Puts Healthcare, Economic Relief for Middle Class First in Prime-Time Special Lexi-Comp Point-of-Care Information Now Available on Smartphones, Coming Soon for the iPhone™

Xenon Light Source

Portable Mini Halogen Light

Micro-Mini Fiber Optic Light - HLT150

Zeon Illuminator

Medicine Products:

Xenon Light Source Portable Mini Halogen Light Micro-Mini Fiber Optic Light - HLT150 Zeon Illuminator

( out Ferring Pharmaceuticals Ferring P...)Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting,Health